+1. This mirrors my journey exactly. The FAERS pharmacovigila discussion here is so valuable.
Slightly tangential to FAERS pharmacovigilance but MeganSA_TX reminded me — has anyone else noticed changes in their alcohol tolerance?
I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.
Saving this for reference. Top-tier content.
Sigma-Aldrich — Research-Grade Standards
Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.
Shop Reference StandardsSlightly tangential to FAERS pharmacovigilance but MeganSA_TX reminded me — what is the latest on the oral formulations?
I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.
Relevant to FAERS pharmacovigilance data — here is my latest bloodwork comparison:
Key improvements: A1C 7.2% → 5.3%, triglycerides 215 → 115 mg/dL, hsCRP 6.0 → 0.9 mg/L. All on tirzepatide for 7 months.
The inflammatory marker drop is what impresses me most. Consistent with the SELECT trial's cardiovascular findings.